Stuffy Adult Vaccine Market, Only One Star ‘Zostavax’

Published: 2014-09-15 09:50:19

Updated: 2014-09-15 10:07:25

It was turned out that Zostavax Inj of shingles vaccine MSD Korea was a real ‘star’ in the adult vaccine market of the first half of this year. It showed a rapid growth since the launch, and reached the record-breaking sales of KRW 24.2 billion only in the first half of this year.

Most of the adult vaccines except for Zostavax Inj. are struggling in the market. Especially, cervical cancer vacc...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.